Variant report

Variant	rs73741618
Chromosome Location	chr6:27726211-27726212
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr6:27670250..27673191-chr6:27723819..27726632,2	K562	blood:

Extended variants
information (count: 25 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:19)

rs_ID	r²[population]
rs56096322	0.82[AFR][1000 genomes]
rs56358872	1.00[AFR][1000 genomes]
rs56393640	1.00[AFR][1000 genomes]
rs57044733	0.82[AFR][1000 genomes]
rs60512267	1.00[AFR][1000 genomes]
rs60542036	1.00[AFR][1000 genomes]
rs60566574	0.94[AFR][1000 genomes]
rs73739689	0.82[AFR][1000 genomes]
rs73739691	1.00[AFR][1000 genomes]
rs73739696	0.82[AFR][1000 genomes]
rs73740807	1.00[AFR][1000 genomes]
rs73740808	0.82[AFR][1000 genomes]
rs73740809	1.00[AFR][1000 genomes]
rs73740816	1.00[AFR][1000 genomes]
rs73740819	0.82[AFR][1000 genomes]
rs73741616	0.94[AFR][1000 genomes]
rs73741620	1.00[AFR][1000 genomes]
rs73741622	0.82[AFR][1000 genomes]
rs73741623	1.00[AFR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:6 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1022797	chr6:27396961-27864277	Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	390 gene(s)	inside rSNPs	diseases
2	nsv883510	chr6:27550712-27730064	Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	37 gene(s)	inside rSNPs	diseases
3	nsv830618	chr6:27593274-27789605	Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	143 gene(s)	inside rSNPs	diseases
4	nsv1031337	chr6:27596676-27734884	Flanking Active TSS Strong transcription Enhancers Bivalent Enhancer Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	36 gene(s)	inside rSNPs	diseases
5	nsv601205	chr6:27656255-27730064	Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Strong transcription Bivalent Enhancer ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	25 gene(s)	inside rSNPs	diseases
6	nsv432858	chr6:27719375-28011652	Flanking Active TSS Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	387 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:42 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:27722600-27728000	Weak transcription	Hela-S3	cervix
2	chr6:27725000-27726400	Active TSS	Fetal Intestine Small	intestine
3	chr6:27725200-27726400	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr6:27725200-27726800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr6:27725600-27726400	Enhancers	Primary T helper cells PMA-I stimulated	--
6	chr6:27725600-27726400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
7	chr6:27725600-27726600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr6:27725600-27726600	Enhancers	Fetal Lung	lung
9	chr6:27725600-27728000	Weak transcription	Osteobl	bone
10	chr6:27725600-27729400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr6:27725600-27730200	Weak transcription	NHEK	skin
12	chr6:27725600-27743000	Weak transcription	Right Atrium	heart
13	chr6:27725800-27726400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr6:27725800-27726600	Enhancers	Primary hematopoietic stem cells short term culture	blood
15	chr6:27725800-27726600	Bivalent Enhancer	Fetal Muscle Leg	muscle
16	chr6:27725800-27726600	Enhancers	Placenta Amnion	Placenta Amnion
17	chr6:27725800-27726600	Flanking Active TSS	K562	blood
18	chr6:27725800-27727000	Flanking Active TSS	Dnd41	blood
19	chr6:27725800-27728200	Weak transcription	HMEC	breast
20	chr6:27725800-27728400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
21	chr6:27725800-27728800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
22	chr6:27725800-27728800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
23	chr6:27726000-27726400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
24	chr6:27726000-27726400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr6:27726000-27726400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
26	chr6:27726000-27726400	Enhancers	Fetal Thymus	thymus
27	chr6:27726000-27726800	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
28	chr6:27726000-27727000	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
29	chr6:27726000-27727800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr6:27726000-27728600	Weak transcription	Primary monocytes fromperipheralblood	blood
31	chr6:27726000-27728800	Weak transcription	Monocytes-CD14+_RO01746	blood
32	chr6:27726000-27729200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
33	chr6:27726200-27726400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
34	chr6:27726200-27726400	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
35	chr6:27726200-27726400	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
36	chr6:27726200-27726400	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr6:27726200-27726400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr6:27726200-27726600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
39	chr6:27726200-27726600	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
40	chr6:27726200-27726600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
41	chr6:27726200-27726600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
42	chr6:27726200-27727600	Enhancers	GM12878-XiMat	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links